Surgical outcomes following encephaloduroarteriosynangiosis in moyamoya disease associated with hyperhomocysteinemia.

Gan GaoFang-Bin HaoQian-Nan WangXiao-Peng WangSi-Meng LiuMin-Jie WangQing-Bao GuoJing-Jie LiXiang-Yang BaoCong HanLian Duan

Published in: Brain and behavior (2023)

HHcy level may be a specific predictor of adverse clinical outcomes after EDAS in patients with MMD and a risk factor for poor collateral circulation and poor prognosis. Patients with MMD complicated with HHcy need to strictly control homocysteine levels before EDAS surgery.

Keyphrases

poor prognosis
long non coding rna
minimally invasive
coronary artery bypass
middle cerebral artery
surgical site infection
adverse drug
acute coronary syndrome
electronic health record
drug induced